1.7  -0.09 (-5.03%)		09-15 16:00
Open: 1.78 High: 1.78 Volume: 11,930		Pre. Close: 1.79 Low: 1.68 Market Cap: 11(M)

Short term
Mid term
Targets	6-month :	2.23	1-year :	2.6
Resists	First :	1.9	Second :	2.23
Pivot price	1.63
Supports	First :	1.63	Second :	1.46
MAs	MA(5) :	1.79	MA(20) :	1.61
	MA(100) :	1.9	MA(250) :	2.79
MACD	MACD :	0	Signal :	0
%K %D	K(14,3) :	67.4	D(3) :	78.2
RSI	RSI(14): 52.5
52-week	High :	5.13	Low :	1.39

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ SINT ] has closed below upper band by 38.1%. Bollinger Bands are 14.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	1.78 - 1.79	1.79 - 1.8
Low:	1.66 - 1.67	1.67 - 1.68
Close:	1.68 - 1.7	1.7 - 1.72

Sintx Technologies, Inc. is an advanced materials enterprise dedicated to researching, developing, and commercializing medical devices crafted from silicon nitride. These innovative products serve biomedical, industrial, and antipathogenic uses, primarily marketed across the United States. Its diverse portfolio includes solid and porous silicon nitride, silicon nitride powder, and specialized coating products, along with advanced silicon nitride composite materials and polyetherketoneketone. Established in 1996, this company, once known as Amedica Corporation, has its corporate headquarters situated in Salt Lake City, Utah.

Mon, 14 Sep 2026
SINTX Technologies Announces Silicon Nitride Masterclass with Leading Orthopedics Experts - The Manila Times

Mon, 14 Sep 2026
Three experts examine a material for orthopedic implants. SINTX sponsors the class. - Stock Titan

Tue, 08 Sep 2026
An implant system cleared by the FDA will be highlighted in New York by SINTX - Stock Titan

Tue, 08 Sep 2026
SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference - Yahoo Finance

Thu, 13 Aug 2026
SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement - Yahoo Finance

Thu, 25 Jun 2026
SINT Forecast — Price Target — Prediction for 2027 - TradingView

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Underperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	7 (M)
Shares Float	6 (M)
Held by Insiders	22.1 (%)
Held by Institutions	14.5 (%)
Shares Short	134 (K)
Shares Short P.Month	153 (K)

EPS	-5.49
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.73
Profit Margin	0 %
Operating Margin	-638.5 %
Return on Assets (ttm)	-74.3 %
Return on Equity (ttm)	-255.9 %
Qtrly Rev. Growth	199.3 %
Gross Profit (p.s.)	0.1
Sales Per Share	0.19
EBITDA (p.s.)	-1.71
Qtrly Earnings Growth	0 %
Operating Cash Flow	-10 (M)
Levered Free Cash Flow	-6 (M)

PE Ratio	-0.32
PEG Ratio	0
Price to Book value	2.32
Price to Sales	8.51
Price to Cash Flow	-1.12

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.